Bentham Science Logo

Track Your Manuscript:

Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research


Letters in Drug Design & Discovery, Volume 3 - Number 4

Structural Analysis of Mogrol and its Glycosides as Inhibitors of Animal DNA Polymerase and Human Cancer Cell Growth

, 3(4): 253 - 260

Yoshiyuki Mizushina, Toshihiro Akihisa, Yousuke Hayakawa, Toshifumi Takeuchi, Isoko Kuriyama, Yuko Yonezawa, Masaharu Takemura, Ikuo Kato, Fumio Sugawara and Hiromi Yoshida

DOI: 10.2174/157018006776743224

Hologram QSAR Studies on Farnesoid X Receptor Activators

, 3(4): 261 - 267

Kathia M. Honorio, Richard C. Garratt, Igor Polikarpov and Adriano D. Andricopulo

DOI: 10.2174/157018006776743206

Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 Inhibitors

, 3(4): 281 - 284

Stefano Moro, Flavia Varano, Giorgio Cozza, Mario A. Pagano, Giuseppe Zagotto, Adriana Chilin, Adriano Guiotto, Daniela Catarzi, Vittoria Calotta and Lorenzo A. Pinna

DOI: 10.2174/157018006776743233


K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05


Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog